Sex hormones and urticaria

Journal of Dermatological Science

Volumn 52, Issue 2, 2008, Pages 79-86

  Kasperska Zajac, A ^a   Brzoza, Z ^a   Rogala, B ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Contraception; Dermatitis; Sex hormones; Urticaria

Indexed keywords

ANTIESTROGEN; ANTIHISTAMINIC AGENT; BUSERELIN; CONJUGATED ESTROGEN; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL PLUS LEVONORGESTREL; ESTRIOL; ESTROGEN; ETHINYL ESTRADIOL PLUS ETHYNODIOL DIACETATE; ETHINYL ESTRADIOL PLUS NORETHINDRONE; ETHINYLESTRADIOL PLUS ETYNODIOL DIACETATE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS PROGESTIN; ETYNODIOL DIACETATE; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE; NORMEGESTREL; ORAL CONTRACEPTIVE AGENT; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; AUTOIMMUNE ESTROGEN INDUCED DERMATITIS; AUTOIMMUNE PROGESTERONE INDUCED DERMATITIS; CELL ACTIVATION; CHRONIC URTICARIA; DERMATITIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOCRINE DISEASE; HORMONAL CONTRACEPTION; HORMONAL REGULATION; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MAST CELL; MENOPAUSE; MENSTRUAL CYCLE; NONHUMAN; ORAL CONTRACEPTION; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SOLAR URTICARIA; URTICARIA;

CHRONIC DISEASE; FEMALE; GONADAL STEROID HORMONES; HUMANS; IMMUNE SYSTEM; MALE; MAST CELLS; SEX CHARACTERISTICS; URTICARIA;

EID: 51249105973     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.04.002     Document Type: Review

References (69)

1. Schocket A.L. Chronic urticaria: pathophysiology and etiology, or the what and why. Allergy Asthma Proc 27 (2006) 90-95
2. Hide M., Francis D.M., Grattan C.E.H., Hakimi J., Kochan J.P., and Greaves M.W. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328 (1993) 1599-1604
3. Tong L.J., Balakrishnan G., Kochan J.P., Kinet J.P., and Kaplan A.P. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol 99 (1997) 461-465
4. Bertinotti L., Miniati I., and Cerinic M.M. Angioedema and systemic sclerosis. A review of the literature. Scand J Rheumatol 31 (2002) 178-180
5. Dagher H.N., Aboujaoude Z.C., and Jabbour S.A. Chronic urticaria: an unusual initial manifestation of primary hyperparathyroidism. Endocr Pract 8 (2002) 47-49
6. Aversano M., Caiazzo P., Iorio G., Ponticiello L., Lagana B., and Leccese F. Improvement of chronic idiopathic urticaria with l-thyroxine: a new TSH role in immune response?. Allergy 60 (2005) 489-493
7. Papadopoulou N., Kalogeromitros D., Staurianeas N.G., Tiblalexi D., and Theoharides T.C. Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. J Invest Dermatol 125 (2005) 952-955
8. Gibbs C.J., Coutts I.I., Lock R., Finnegan O.C., and White R.J. Premenstrual exacerbation of asthma. Thorax 39 (1984) 833-836
9. Beynon H.L.C., Garbett N.D., and Barnes P.J. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 8 (1988) 370-371
10. Kemmett D. Premenstrual exacerbation of atopic dermatitis. Br J Dermatol 120 (1989) 715
11. Yell J.A., and Burge S.M. The effect of hormonal changes on cutaneous disease in lupus erythematosus. Br J Dermatol 129 (1993) 18-22
12. Bork K., Fischer B., and Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 114 (2003) 294-298
13. Agostoni A., Aygoren-Pursun E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114 3 Suppl. (2004) S51-131
14. Yip J., and Cunliffe W.J. Hormonally exacerbated hereditary angioedema. Australas J Dermatol 33 (1992) 35-38
15. Visy B., Fust G., Varga L., Szendei G., Takacs E., Karadi I., et al. Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf) 60 (2004) 508-515
16. Buss Y.A., Garrelfs U.C., and Sticherling M. Chronic urticaria-which clinical parameters are pathogenetically relevant? A retrospective investigation of 339 patients. J Dtsch Dermatol Ges 5 (2007) 22-27
17. Greaves M.W. Chronic urticaria. N Engl J Med 332 (1995) 1767-1772
18. Cutolo M., Villaggio B., Craviotto C., Pizzorni C., Seriolo B., and Sulli A. Sex hormones and rheumatoid arthritis. Autoimmun Rev 1 (2002) 284-289
19. Tanriverdi F., Silveira L.F., MacColl G.S., and Bouloux P.M. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity. J Endocrinol 176 (2003) 293-304
20. Watson C.S., and Gametchu B. Membrane estrogen and glucocorticoid receptors-implications for hormonal control of immune function and autoimmunity. Int Immunopharmacol 1 (2001) 1049-1063
21. Canesi L., Ciacci C., Lorusso L.C., Betti M., Guarnieri T., Tavolari S., et al. Immunomodulation by 17beta-estradiol in bivalve hemocytes. Am J Physiol Regul Integr Comp Physiol 291 (2006) R664-673
22. Mathur S., Mathur R.S., Goust J.M., and Nuran A. Cyclic variations in the human menstrual cycle: correlations with progesterone and estradiol. Clin Immunol Immunopathol 13 (1979) 246-253
23. Ackerman L.S. Sex hormones and the genesis of autoimmunity. Arch Dermatol 142 (2006) 371-376
24. Cocchiara R., Albeggiani G., Di-Trapani G., Azzolina A., Lampiasi N., Rizzo F., et al. Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens. Int Arch Allergy Appl Immunol 93 (1990) 192-197
25. Vliagoftis H., Dimitriadou V., Boucher W., Rozniecki J.J., Correia I., Raam S., et al. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int Arch Allergy Immunol 98 (1992) 398-409
26. Zaitsu M., Narita S., Lambert K.C., Grady J.J., Estes D.M., Curran E.M., et al. Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 44 (2007) 1977-1985
27. Vasiadi M., Kempuraj D., Boucher W., Kalogeromitros D., and Theoharides T.C. Progesterone inhibits mast cell secretion. Int J Immunopathol Pharmacol 19 (2006) 787-794
28. Mittman R.J., Bernstein D.I., Steinberg D.R., Enrione M., and Bernstein I.L. Progesterone-responsive urticaria and eosinophilia. J Allergy Clin Immunol 84 (1989) 304-310
29. Narita S., Goldblum R.M., Watson C.S., Brooks E.G., Estes D.M., Curran E.M., et al. Environmental estrogens induce mast cell degranulation and enhance IgE-mediated release of allergic mediators. Environ Health Perspect 115 (2007) 48-52
30. Newbold R.R., Padilla-Banks E., and Jefferson W.N. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 147 6 Suppl. (2006) 11-17
31. 2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ Health Perspect 113 (2005) 431-439
32. Watson C.S., Bulayeva N.N., Wozniak A.L., and Finnerty C.C. Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens, and phytoestrogens. Steroids 70 (2005) 364-371
33. Tapiero H., Ba G.N., and Tew K.D. Estrogens and environmental estrogens. Biomed Pharmacother 56 (2002) 36-44
34. Herzberg A.J., Strohmeyer C.R., and Cirillo-Hyland V.A. Autoimmune progesterone dermatitis. J Am Acad Dermatol 32 2 Pt 2 (1995) 333-338
35. Vasconcelos C., Xavier P., Vieira A.P., Martinho M., Rodrigues J., Bodas A., et al. Autoimmune progesterone urticaria. Gynecol Endocrinol 14 (2000) 245-247
36. Stephens C.J., Wojnarowska F.T., and Wilkinson J.D. Autoimmune progesterone dermatitis responding to Tamoxifen. Br J Dermatol 121 (1989) 135-137
37. Snyder J.L., and Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann Allergy Asthma Immunol 90 (2003) 469-477
38. Moghadam B.K., Hersini S., and Barker B.F. Autoimmune progesterone dermatitis and stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 537-541
39. Anderson R.H. Autoimmune progesterone dermatitis. Cutis 33 (1984) 490-491
40. Oskay T., Kutluay L., Kaptanoglu A., and Karabacak O. Autoimmune progesterone dermatitis. Eur J Dermatol 12 (2002) 589-591
41. Wojnarowska F., Greaves M.W., Peachey R.D., Drury P.L., and Besser G.M. Progesterone-induced erythema multiforme. J R Soc Med 78 (1985) 407-408
42. Yee K.C., and Cunliffe W.J. Progesterone-induced urticaria: response to buserelin. Br J Dermatol 130 (1994) 121-123
43. Shelley W.B., Shelley E.D., Talanin N.Y., and Santoso-Pham J. Estrogen dermatitis. J Am Acad Dermatol 32 (1995) 25-31
44. Yotsumoto S., Shimomai K., Hashiguchi T., Uchimiya H., Usuki K., Nishi M., et al. Estrogen dermatitis: a dendritic-cell-mediated allergic condition. Dermatology 207 (2003) 265-268
45. Leylek O.A., Unlu S., Ozturkcan S., Cetin A., Sahin M., and Yildiz E. Estrogen dermatitis. Eur J Obstet Gynecol Reprod Biol 72 (1997) 97-103
46. Mayou S.C., Charles-Holmes R., Kenney A., and Black M.M. A premenstrual urticarial eruption treated with bilateral oophorectomy and hysterectomy. Clin Exp Dermatol 13 (1988) 114-116
47. Randall K., and Steele R. Estrogen dermatitis: treatment with progestin-only pill. Arch Dermatol 141 (2005) 792-793
48. Kasperska-Zajac A., Brzoza Z., and Rogala B. Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria. J Dermatol Sci 41 (2006) 80-81
49. Kasperska-Zajac A., Brzoza Z., and Rogala B. Lower serum concentration of dehydyroepiandrone sulphate in patients with chronic idiopathic urticaria. Allergy 61 (2006) 1489-1490
50. Brzoza Z., Kasperska-Zajac A., and Rogala B. Serum prolactin concentration and its relationship with dehydroepiandrosterone sulfate concentration in chronic urticaria patients with positive and negative response to autologous serum skin test. Allergy 62 (2007) 566-567
51. Kasperska-Zajac A., Brzoza Z., and Rogala B. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine 39 (2007) 142-146
52. Zouboulis C.C., Chen W.C., Thornton M.J., Qin K., and Rosenfield R. Sexual hormones in human skin. Horm Metab Res 39 (2007) 85-95
53. Labrie F., Luu-The V., Belanger A., Lin S.X., Simard J., Pelletier G., et al. Is dehydroepiandrosterone a hormone?. J Endocrinol 187 (2005) 169-196
54. Friel P.N., Alexander T., and Wright J.V. Suppression of adrenal function by low-dose prednisone: assessment with 24-hour urinary steroid hormone profiles-a review of five cases. Altern Med Rev 11 (2006) 40-46
55. Barry N.N., McGuire J.L., and van Vollenhoven R.F. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response. J Rheumatol 25 (1998) 2352-2356
56. Dillon J.S. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr Drug Targets Inflamm Allergy 4 (2005) 377-385
57. Kasperska-Zajac A., Brzoza Z., Badura-Brzoza K., Matysiakiewicz J., Hese R.T., and Rogala B. Does the dehydroepiandrosterone sulphate decline in chronic urticaria result from psychological distress?. Allergy 62 (s83) poster (2007) 1640
58. Brzoza Z, Kasperska-Zajac A, Badura-Brzoza K, Matysiakiewicz J, Hese RT, Rogala B. Decline in dehydroepiandrosterone sulphate observed in chronic urticaria is associated with psychological distress. Psychosom Med 2008; in press.
59. Kumar M.A., and Gupta C. Acquired angioedema secondary to hormone replacement therapy. Indian J Med Sci 59 (2005) 451-454
60. Gordon E.M., Ratnoff O.D., Saito H., Donaldson V.H., Pensky J., and Jones P.K. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased C1 esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 96 (1980) 762-769
61. Zaun H. Skin changes from taking hormonal contraceptives. Med Monatsschr Pharm 4 (1981) 161-165
62. Thomas P., Dalle E., Revillon B., Delecour M., Devarenne-nicolle M.F., and Pagniez I. Cutaneous effects in hormonal contraception. NPN Med 5 (1985) 19-24
63. Morison W.L. Solar urticaria due to progesterone compounds in oral contraceptives. Photodermatol Photoimmunol Photomed 19 (2003) 155-156
64. Arowojolu A.O., and Ladipo O.A. Nonmenstrual adverse events associated with subdermal contraceptive implants containing normegestrel and levonorgestrel. Afr J Med Med Sci 32 (2003) 27-31
65. Andre F., Veysseyre-Balter C., Rousset H., Descos L., and Andre C. Exogenous oestrogen as an alternative to food allergy in the aetiology of angioneurotic oedema. Toxicology 185 (2003) 155-160
66. Resnik S.S. Melasma and other skin manifestations or oral contraceptives. Trans N Engl Obstet Gynecol Soc 21 (1967) 101-107
67. Humphreys F., and Hunter J.A.A. The characteristics of urticaria in 390 patients. Br J Dermatol 138 (1998) 635-638
68. Schatz M., and Zeiger R.S. Asthma and allergy in pregnancy. Clin Perinatol 24 (1997) 407-432
69. Brzoza Z., Kasperska-Zajac A., Oles E., and Rogala B. Pruritic urticarial papules and plaques of pregnancy. J Midwifery Womens Health 52 (2007) 44-48